» Articles » PMID: 19644848

The Role of Neutrophil Apoptosis in Juvenile-onset Systemic Lupus Erythematosus

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2009 Aug 1
PMID 19644848
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Accumulation of apoptotic cells may lead to the development of systemic lupus erythematosus (SLE) through a breakdown in immune tolerance. Altered neutrophil apoptosis may contribute to nuclear autoantigen exposure, ultimately leading to autoantibody generation. This study aimed to determine whether neutrophil apoptosis is altered in patients with juvenile-onset SLE as compared with controls.

Methods: Apoptosis was measured in neutrophils from patients with juvenile-onset SLE (n=12), adult-onset SLE (n=6), and pediatric patients with inflammatory (n=12) and noninflammatory (n=12) conditions. Annexin V staining and flow cytometry were used to determine neutrophil apoptosis. Proapoptotic and antiapoptotic proteins were measured in sera and in neutrophil cell lysates.

Results: Neutrophil apoptosis was significantly increased in patients with juvenile-onset SLE as compared with the noninflammatory controls at time 0. Incubation of neutrophils with sera from patients with juvenile-onset SLE further increased neutrophil apoptosis as compared with incubation with sera from pediatric controls. Concentrations of TRAIL and FasL were significantly increased in sera from patients with juvenile-onset SLE, whereas interleukin-6, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor (GM-CSF) were significantly decreased. Addition of GM-CSF to sera from patients with juvenile-onset SLE significantly decreased neutrophil apoptosis as compared with juvenile-onset SLE sera alone. The expression of proapoptotic proteins (caspase 3, Fas, and FADD) was elevated in juvenile-onset SLE neutrophils, whereas the expression of antiapoptotic proteins (cellular inhibitor of apoptosis 1 and 2 and X-linked inhibitor of apoptosis) was decreased. Neutrophil apoptosis correlated with biomarkers of disease activity (erythrocyte sedimentation rate and double-stranded DNA concentration) and the British Isles Lupus Assessment Group disease activity score.

Conclusion: Our data demonstrate an imbalance in proapoptotic and antiapoptotic factors in both neutrophils and sera from patients with juvenile-onset SLE. This imbalance results in increased neutrophil apoptosis in these patients. Correlations with markers of disease activity indicate that altered neutrophil apoptosis in juvenile-onset SLE patients may play a pathogenic role in this condition.

Citing Articles

KLF2 controls the apoptosis of neutrophils and is associated with disease activity of systemic lupus erythematosus.

Zhao H, Lin Z, Zhang P, Rao J, Xu S, Luo Q Arthritis Res Ther. 2024; 26(1):222.

PMID: 39702240 PMC: 11658319. DOI: 10.1186/s13075-024-03461-z.


Blood Growth Factor Levels in Patients with Systemic Lupus Erythematosus: High Neuregulin-1 Is Associated with Comorbid Cardiovascular Pathology.

Ermakov E, Melamud M, Boiko A, Ivanova S, Sizikov A, Nevinsky G Life (Basel). 2024; 14(10).

PMID: 39459605 PMC: 11509485. DOI: 10.3390/life14101305.


A systematic review and meta-analysis of the diagnostic accuracy of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in systemic lupus erythematosus.

Zinellu A, Paliogiannis P, Mangoni A Clin Exp Med. 2024; 24(1):170.

PMID: 39052098 PMC: 11272706. DOI: 10.1007/s10238-024-01438-5.


Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.

Liphaus B, Silva S, Palmeira P, Silva C, Goldenstein-Schainberg C, Carneiro-Sampaio M Front Immunol. 2024; 15:1327255.

PMID: 38562920 PMC: 10982494. DOI: 10.3389/fimmu.2024.1327255.


Neutrophil cytosolic factor 2 (NCF2) gene polymorphism is associated with juvenile-onset systemic lupus erythematosus, but probably not with other autoimmune rheumatic diseases in children.

Bakutenko I, Haurylchyk I, Nikitchenko N, Sechko E, Kozyro I, Tchitchko A Mol Genet Genomic Med. 2021; 10(1):e1859.

PMID: 34971477 PMC: 8801135. DOI: 10.1002/mgg3.1859.